Ebtehal El‐Demerdash
- Pharmacology top 1%
- Drug-Induced Hepatotoxicity and Protection 8
- Hepatology top 5%
- Liver physiology and pathology 10
- Geriatrics and Gerontology top 5%
- Biochemistry top 5%
-
- Liver Disease Diagnosis and Treatment 15
-
- Cancer-related cognitive impairment studies 9
-
- Reproductive Biology and Fertility 7
-
- Tryptophan and brain disorders 6
-
- Bioactive Compounds and Antitumor Agents 5
-
- Chemotherapy-induced cardiotoxicity and mitigation 5
- Co-authors
- Wesam M. El‐BaklyEman M. MantawyAhmed EsmatHala O. El‐MesallamyRiham S. SaidSara A. WahdanAshraf B. Abdel‐NaimDoaa A. Elsherbiny
- Journals
- Toxicology and Applied Pharmacology (7 papers)European Journal of Pharmacology (5 papers)Life Sciences (5 papers)
- Partner nations
- EgyptSaudi ArabiaUnited States
In The Last Decade
Ebtehal El‐Demerdash
79 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 117
- Pharmacology 288
- Hepatology 174
- Geriatrics and Gerontology 70
- Complementary and alternative medicine 145
- Biochemistry 103
Countries citing papers authored by Ebtehal El‐Demerdash
This map shows the geographic impact of Ebtehal El‐Demerdash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebtehal El‐Demerdash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebtehal El‐Demerdash more than expected).
Fields of papers citing papers by Ebtehal El‐Demerdash
This network shows the impact of papers produced by Ebtehal El‐Demerdash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebtehal El‐Demerdash. The network helps show where Ebtehal El‐Demerdash may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ebtehal El‐Demerdash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 18 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 38 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 68 | |
| 9 | 2020 | 29 | |
| 10 | 2019 | 9 | |
| 11 | 2016 | 14 | |
| 12 | 2016 | 62 | |
| 13 | 2013 | 20 | |
| 14 | 2013 | 54 | |
| 15 | 2013 | 38 | |
| 16 | 2012 | 44 | |
| 17 | 2012 | 98 | |
| 18 | 2010 | 30 | |
| 19 | 2004 | 3 | |
| 20 | 2004 | 12 |
About Ebtehal El‐Demerdash
Ebtehal El‐Demerdash is a scholar working on Biological Psychiatry, Hepatology, Toxicology, Pharmacology and Behavioral Neuroscience, having authored 82 papers that have together received 2.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (15 papers), Liver physiology and pathology (10 papers), Cancer-related cognitive impairment studies (9 papers), Drug-Induced Hepatotoxicity and Protection (8 papers), Reproductive Biology and Fertility (7 papers), Tryptophan and brain disorders (6 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Chemotherapy-induced cardiotoxicity and mitigation (5 papers). The work is most often cited by research in Pharmacology (288 citations), Hepatology (174 citations), Geriatrics and Gerontology (70 citations), Complementary and alternative medicine (145 citations) and Biochemistry (103 citations). Ebtehal El‐Demerdash has collaborated with scholars based in Egypt, Saudi Arabia and United States. Frequent co-authors include Wesam M. El‐Bakly, Eman M. Mantawy, Ahmed Esmat, Hala O. El‐Mesallamy, Riham S. Said, Sara A. Wahdan, Ashraf B. Abdel‐Naim, Doaa A. Elsherbiny, Amira M. Badr and Nadia Μ. Hamdy. Their work appears in journals such as Toxicology and Applied Pharmacology, European Journal of Pharmacology, Life Sciences, Scientific Reports and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.